Gerhard Krammer

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

Thomas J. Schnitzer, Gerd R Burmester, Eduardo Mysler et al. · The Lancet · 2004 · 700 citations

Rheumatology, Anti-inflammatory, Anti-inflammatory Agents +9

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

Michael E. Farkouh, Howard S. Kirshner, Robert A. Harrington et al. · The Lancet · 2004 · 490 citations

Rheumatoid Disorder, Rheumatology, Anti-inflammatory +10

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions

Naomi Schlesinger, Rieke Alten, Thomas Bardin et al. · Annals of the Rheumatic Diseases · 2012 · 338 citations

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study

Naomi Schlesinger, Eduardo Mysler, Hsiao‐Yi Lin et al. · Annals of the Rheumatic Diseases · 2011 · 236 citations · Full text

From Wine to Pepper: Rotundone, an Obscure Sesquiterpene, Is a Potent Spicy Aroma Compound

Claudia Wood, Tracey Siebert, Mango Parker et al. · Journal of Agricultural and Food Chemistry · 2008 · 225 citations